Clinical Trials Directory

Trials / Sponsors / Tuberculosis Research Centre, India

Tuberculosis Research Centre, India

Other Government · 14 registered clinical trials1 currently recruiting.

StatusTrialPhaseStarted
SuspendedBCG Revaccination in Children and Adolescents
Tuberculosis Infection, Tuberculosis
Phase 32024-07-15
UnknownFour Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients
Tuberculosis, Pulmonary
2022-03-15
UnknownModified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India
Pre-Extensively Drug-Resistant Pulmonary TB, Treatment Intolerant Multidrug-Resistant Pulmonary TB, Non-responsive Multidrug-Resistant Pulmonary TB
Phase 32021-10-07
UnknownEffect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tubercu
COVID-19 Respiratory Infection, Pulmonary Tuberculoses
2021-06-21
CompletedCharacterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers
Covid19
2021-05-07
UnknownComorbidities and Coinfections in Latent TB
Latent Tuberculosis, Diabete Mellitus, Malnutrition
2021-04-19
RecruitingMISC COVID-19 Study in Pediatric Population
SARS-CoV2 Infection, Multisystem Inflammatory Syndrome in Children
2020-12-23
Active Not RecruitingThe Impact of Malnutrition on Immune Responses to Tuberculosis
Malnutrition, Child, Tuberculosis
2020-08-01
CompletedBCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots
COVID
Phase 32020-07-01
CompletedLatency in Pulmonary Tuberculosis
Pulmonary Tuberculosis
Phase 32010-02-01
CompletedComparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis
HIV Infection, Pulmonary TB
Phase 32009-09-14
UnknownSafety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatmen
Tuberculosis, Human Immunodeficiency Virus Infections
Phase 32006-06-01
UnknownShort Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis
Tuberculosis, Human Immunodeficiency Virus Infections
Phase 32001-02-01
CompletedPreventive Therapy for Tuberculosis in HIV Infected Persons
Human Immunodeficiency Virus, Tuberculosis
Phase 32001-02-01